Form 8-K - Current report:
SEC Accession No. 0001104659-24-131554
Filing Date
2024-12-26
Accepted
2024-12-26 09:00:30
Documents
20
Period of Report
2024-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2430640d5_8k.htm   iXBRL 8-K 48846
2 EXHIBIT 1.1 tm2430640d5_ex1-1.htm EX-1.1 63523
3 EXHIBIT 4.1 tm2430640d5_ex4-1.htm EX-4.1 108636
4 EXHIBIT 4.2 tm2430640d5_ex4-2.htm EX-4.2 112054
5 EXHIBIT 4.3 tm2430640d5_ex4-3.htm EX-4.3 103726
6 EXHIBIT 4.4 tm2430640d5_ex4-4.htm EX-4.4 16314
7 EXHIBIT 10.1 tm2430640d5_ex10-1.htm EX-10.1 220923
8 EXHIBIT 99.1 tm2430640d5_ex99-1.htm EX-99.1 10217
  Complete submission text file 0001104659-24-131554.txt   1030199

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA qnrx-20241220.xsd EX-101.SCH 3024
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE qnrx-20241220_lab.xml EX-101.LAB 34240
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qnrx-20241220_pre.xml EX-101.PRE 22365
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2430640d5_8k_htm.xml XML 3634
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 8-K | Act: 34 | File No.: 001-37846 | Film No.: 241576890
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)